Tenoxicam
96 interactions 5 explained in plain English
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jul 4, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Most serious with:
Ketorolac Ophthalmic
Ketorolac
Ketorolac Nasal Spray
Ketorolac Injection
Melphalan Injection
Fondaparinux
Major
Tenoxicam Amitriptyline Elavil Explained An increased risk of bleeding Details Tenoxicam Sertraline Explained An increased risk of bleeding Details Tenoxicam Apixaban Eliquis Explained An increased risk of bleeding Details Tenoxicam Aspirin Acuprin® An increased risk of bleeding, decreased renal function, and an increased risk of gastrointestinal adverse events Details Tenoxicam Aspirin Rectal Aspirin An increased risk of bleeding, decreased renal function, and an increased risk of gastrointestinal adverse events Details Tenoxicam Betrixaban Bevyxxa® An increased risk of bleeding Details Tenoxicam Anagrelide Agrylin An increased risk of bleeding Details Tenoxicam Bromfenac Ophthalmic Bromday® Increased risk of bleeding Details Tenoxicam Budesonide Entocort Increased risk of gastrointestinal ulcer or bleeding Details Tenoxicam Budesonide Nasal Spray Rhinocort Increased risk of gastrointestinal ulcer or bleeding Details Tenoxicam Budesonide Oral Inhalation Pulmicort Increased risk of gastrointestinal ulcer or bleeding Details Tenoxicam Capecitabine Xeloda Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Tenoxicam Clopidogrel Plavix An increased risk of bleeding Details Tenoxicam Cyclosporine Injection Atopica An increased risk of cycloSPORINE nephrotoxicity Details Tenoxicam Cyclosporine Ophthalmic Cequa An increased risk of cycloSPORINE nephrotoxicity Details Tenoxicam Dabigatran Pradaxa® An increased risk of bleeding Details Tenoxicam Dabigatran Etexilate An increased risk of bleeding Details Tenoxicam Dalteparin Injection Fragmin An increased risk of bleeding Details Tenoxicam Deflazacort Emflaza Increased risk of gastrointestinal ulcer or bleeding Details Tenoxicam Dexamethasone Injection Decadron Increased risk of gastrointestinal ulcer or bleeding Details Tenoxicam Dexamethasone Ophthalmic Dexacidin® (as a combination product containing Dexamethasone, Neomycin, Polymyxin B) Increased risk of gastrointestinal ulcer or bleeding Details Tenoxicam Diclofenac Ophthalmic Voltaren® Eye Drops Increased risk of bleeding Details Tenoxicam Diclofenac Topical (Actinic Keratosis) Pennsaid Increased risk of bleeding Details Tenoxicam Diclofenac Topical (Arthritis Pain) Pennsaid® Increased risk of bleeding Details Tenoxicam Diclofenac Transdermal Patch Flector Increased risk of bleeding Details Tenoxicam Digoxin Cardoxin® Increased digoxin exposure and prolonged half-life of digoxin Details Tenoxicam Dipyridamole Permole® An increased risk of bleeding Details Tenoxicam Edoxaban Savaysa An increased risk of bleeding Details Tenoxicam Emtricitabine Emtriva Increased emtricitabine exposure and an increased risk of emtricitabine-related adverse effects Details Tenoxicam Enoxaparin Lovenox An increased risk of bleeding Details Tenoxicam Enoxaparin Injection Lovenox An increased risk of bleeding Details Tenoxicam Epoprostenol Flolan An increased risk of bleeding Details Tenoxicam Etodolac Lodine Increased risk of bleeding Details Tenoxicam Fenoprofen Fenopron Increased risk of bleeding Details Tenoxicam Fluorouracil Adrucil Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Tenoxicam Fluorouracil Injection Adrucil Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Tenoxicam Fluorouracil Topical Carac Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Tenoxicam Flurbiprofen Ansaid Increased risk of bleeding Details Tenoxicam Flurbiprofen Ophthalmic Ocufen Increased risk of bleeding Details Tenoxicam Fondaparinux Arixtra An increased risk of bleeding DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.